114 related articles for article (PubMed ID: 33583579)
1. Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer ꟷ The Extreme study.
Baandrup L; Dehlendorff C; Hertzum-Larsen R; Hannibal CG; Kjaer SK
Gynecol Oncol; 2021 May; 161(2):458-462. PubMed ID: 33583579
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study.
Duus AH; Hannibal CG; Baandrup L; Zheng G; Galanakis M; Maltesen T; Hertzum-Larsen R; Mørch LS; Kjær SK
Int J Cancer; 2024 Jul; 155(1):19-26. PubMed ID: 38532545
[TBL] [Abstract][Full Text] [Related]
3. Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996-2017.
Faber MT; Horsbøl TA; Baandrup L; Dalton SO; Kjaer SK
Gynecol Oncol; 2022 Jan; 164(1):98-104. PubMed ID: 34763941
[TBL] [Abstract][Full Text] [Related]
4. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic status and epithelial ovarian cancer survival in Sweden.
Weiderpass E; Oh JK; Algeri S; Bellocco R
Cancer Causes Control; 2014 Aug; 25(8):1063-73. PubMed ID: 24906473
[TBL] [Abstract][Full Text] [Related]
6. History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme study.
Hannibal CG; Kjaer SK; Galanakis M; Hertzum-Larsen R; Maltesen T; Baandrup L
Gynecol Oncol; 2024 Mar; 182():1-6. PubMed ID: 38246041
[TBL] [Abstract][Full Text] [Related]
7. Do stage of disease, comorbidity or access to treatment explain socioeconomic differences in survival after ovarian cancer? - A cohort study among Danish women diagnosed 2005-2010.
Ibfelt EH; Dalton SO; Høgdall C; Fagö-Olsen CL; Steding-Jessen M; Osler M; Johansen C; Frederiksen K; Kjær SK
Cancer Epidemiol; 2015 Jun; 39(3):353-9. PubMed ID: 25841586
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of marital status on survival of women with epithelial ovarian cancer.
Mahdi H; Kumar S; Munkarah AR; Abdalamir M; Doherty M; Swensen R
Psychooncology; 2013 Jan; 22(1):83-8. PubMed ID: 21919121
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic status and survival of cirrhosis patients: a Danish nationwide cohort study.
Jepsen P; Vilstrup H; Andersen PK; Sørensen HT
BMC Gastroenterol; 2009 May; 9():35. PubMed ID: 19450284
[TBL] [Abstract][Full Text] [Related]
10. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
11. Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012.
Edwards HM; Noer MC; Sperling CD; Nguyen-Nielsen M; Lundvall L; Christensen IJ; Høgdall C
Acta Oncol; 2016 Jun; 55 Suppl 2():36-43. PubMed ID: 27355258
[TBL] [Abstract][Full Text] [Related]
12. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.
Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ
Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381
[TBL] [Abstract][Full Text] [Related]
13. Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study.
Dahm-Kähler P; Holmberg E; Holtenman M; Rådestad AF; Borgfeldt C; Hjerpe E; Marcickiewicz J; Bjurberg M; Tholander B; Hellman K; Kjølhede P; Högberg T; Rosenberg P; Åvall-Lundqvist E; Stålberg K
Gynecol Oncol; 2021 Apr; 161(1):244-250. PubMed ID: 33581846
[TBL] [Abstract][Full Text] [Related]
14. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
Hannibal CG; Cortes R; Engholm G; Kjaer SK
Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.
Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE
Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132
[TBL] [Abstract][Full Text] [Related]
16. Increased disease-free and relative survival in advanced ovarian cancer after centralized primary treatment.
Palmqvist C; Staf C; Mateoiu C; Johansson M; Albertsson P; Dahm-Kähler P
Gynecol Oncol; 2020 Nov; 159(2):409-417. PubMed ID: 32943206
[TBL] [Abstract][Full Text] [Related]
17. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
[TBL] [Abstract][Full Text] [Related]
18. Impact of socioeconomic status on survival in patients with ovarian cancer.
Gardy J; Dejardin O; Thobie A; Eid Y; Guizard AV; Launoy G
Int J Gynecol Cancer; 2019 May; 29(4):792-801. PubMed ID: 30712018
[TBL] [Abstract][Full Text] [Related]
19. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
Cabasag CJ; Butler J; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Møller B; Gavin A; Norell CH; Harrison S; Saint-Jacques N; Eden M; Rous B; Nordin A; Hanna L; Kwon J; Cohen PA; Altman AD; Shack L; Kozie S; Engholm G; De P; Sykes P; Porter G; Ferguson S; Walsh P; Trevithick R; Tervonen H; O'Connell D; Bray F; Soerjomataram I
Gynecol Oncol; 2020 Apr; 157(1):234-244. PubMed ID: 32005583
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenectomy in surgical stage I epithelial ovarian cancer.
Svolgaard O; Lidegaard O; Nielsen ML; Nedergaard L; Mosgaard BJ; Lidang M; Mogensen O; Kock K; Blaakaer J; Staehr E; Andersen ES; Grove A; Høgdall C
Acta Obstet Gynecol Scand; 2014 Mar; 93(3):256-60. PubMed ID: 24447203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]